Preprint · CC-BY
via OpenAlex
Deregulated transcription factors in the emerging cancer hallmarks
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin M.S., Abdul Q. Khan, Martin S. Steinhoff
Seminars in Cancer Biology · 2023 · ▲ 44 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.semcancer.2023.12.001
- Canonical
- link ↗
- Fetched
- 2026-09-26 MST
Cite this
APA
Hasan, A., Khan, N.A., M.S., S.U., Khan, A.Q., & Steinhoff, M.S. (2023). Deregulated transcription factors in the emerging cancer hallmarks. <em>Seminars in Cancer Biology</em>. https://doi.org/10.1016/j.semcancer.2023.12.001
Vancouver
Hasan A, Khan NA, M.S. SU, Khan AQ, Steinhoff MS. Deregulated transcription factors in the emerging cancer hallmarks. Seminars in Cancer Biology. 2023. doi:10.1016/j.semcancer.2023.12.001.
BibTeX
@unpublished{adria2023Deregu,
title = {Deregulated transcription factors in the emerging cancer hallmarks},
author = {Adria Hasan and Naushad Ahmad Khan and Shahab Uddin M.S. and Abdul Q. Khan and Martin S. Steinhoff},
journal = {Seminars in Cancer Biology},
year = {2023},
doi = {10.1016/j.semcancer.2023.12.001},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Death and Differentiation 2007
Open access · OA
Tumour-released exosomes and their implications in cancer immunity
Infection and Immunity 2004
Preprint · OA
Gastric Transcription Profile of Helicobacter pylori Infection in the Rhesus Macaque
Genes & Development 2019
Open access · CC-BY
MITF—the first 25 years
Seminars in Cancer Biology 2017
Open access · CC-BY
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
Signal Transduction and Targeted Therapy 2020
Open access · CC-BY
Targeting cancer stem cell pathways for cancer therapy
Trends in Endocrinology and Metabolism 2025
Open access · CC-BY